Research areas
GLP-1 / GIP agonists
Incretin receptor agonists: Retatrutide and Tirzepatide for research.
Incretin receptor agonists for research
This area covers synthetic peptides acting on incretin receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon receptors.
- Tirzepatide – a 39-amino-acid peptide, a dual GIP and GLP-1 receptor agonist.
- Retatrutide – a 39-amino-acid peptide activating three receptors at once: GIP, GLP-1 and glucagon.
Research uses
- Receptor binding and signalling (cAMP) studies in cell models.
- Comparing dual and triple agonism in vitro.
- Peptide stability and analytical method development (HPLC, MS).
Every batch comes with a COA (HPLC purity ≥ 99%). Lyophilised powder in a sealed glass vial; store at 2–8 °C.
All products are for in-vitro laboratory research only. Not for human or animal use.
